LOC728739: A Potential Drug Target for Cell Death and Tissue Repair

Target Name: LOC728739

NCBI ID: G728739

LOC728739

Other Name(s): programmed cell death 2 pseudogene | Programmed cell death 2 pseudogene

LOC728739: A Potential Drug Target for Cell Death and Tissue Repair

LOC728739 is a 5' endogenous RNA molecule that is expressed in a variety of tissues and cells throughout the body. It is a member of the programmed cell death (PD) gene family, which is known for its role in regulating cell death and cell survival. PD genes have been implicated in a wide range of cellular processes, including cell growth, differentiation, and stress resistance.

LOC728739 is characterized by its ability to induce cell death, both in cell culture and in vivo. Studies have shown that LOC728739 can induce cell death in a variety of cell types, including neurons, macrophages, and cancer cells. This is accomplished through a variety of mechanisms, including the inhibition of cell cycle progression and the activation of caspases, which are key components of the cell death signaling pathway.

In addition to its ability to induce cell death, LOC728739 has also been shown to be involved in the regulation of cell survival. Studies have shown that LOC728739 can inhibit the inhibition of cell survival, which is typically caused by the inhibition of apoptosis (programmed cell death) by pro-inflammatory signaling pathways. This suggests that LOC728739 may have potential as a drug target for a variety of conditions, including cancer, neurodegenerative diseases, and chronic inflammatory diseases.

LOC728739 has also been shown to be involved in the regulation of cellular processes that are important for tissue repair and regeneration. Studies have shown that LOC728739 can promote the expression of genes that are involved in tissue repair and regeneration, such as the stem cell gene Sox2. This suggests that LOC728739 may have potential as a drug target for tissue repair and regeneration-related conditions.

In conclusion, LOC728739 is a 5' endogenous RNA molecule that is expressed in a variety of tissues and cells throughout the body. It is a member of the programmed cell death (PD) gene family and has been shown to have a variety of cellular processes involved in cell death and cell survival. In addition, LOC728739 has also been shown to be involved in the regulation of tissue repair and regeneration. These properties make LOC728739 a potential drug target for a variety of conditions, including cancer, neurodegenerative diseases, and chronic inflammatory diseases. Further research is needed to fully understand the role of LOC728739 in these processes and to determine its potential as a drug.

Protein Name: Programmed Cell Death 2 Pseudogene

The "LOC728739 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC728739 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets